hrs4r
 I want to donate

ANDER TIMOTEO DELGADO

Firma
ANDER TIMOTEO-DELGADO
Position
Investigadors/es Col·laboradors/es
Collaborators

Projectes

Codi oficial: IMPROSA Start date:01/04/2022 Data fi: 30/06/2023 Investigador/a principal: ERNESTO BARZOLA NAVARRO Organisme finançador: F. ASOC. ESP. COLOPROCTOLOGIA Ajuda: 6,600 €

Publicacions

Hidalgo-Pujol M, Biondo S, Die Trill J, Vigorita V, Paniagua Garcia-Señorans M, Pascual Migueláñez I, Prieto-La Noire F, Timoteo A, Cornejo L, Martín Parra JI, Fidalgo García M, Solís-Peña A, Cirera de Tudela A, Rodriguez González A, Sánchez-Guillen L, Bustamante Recuenco C, Pérez-Alonso C, Hurtado Caballero E, Pascual M, García Septiem J, Mora López L, Cervera-Aldama J, Guadalajara H, Espín E, Kreisler E

Upfront surgery versus self-expanding metallic stent as bridge to surgery in left-sided colonic cancer obstruction: A multicenter observational study

Surgery, 2022, 172, 74-82 dx.doi.org/10.1016/j.surg.2021.12.035
0

Prognostic significance of the microbiome-adipose tissue axis in rectal cancer: protocol of a prospective observational study

BJS Open, 2022, 6 dx.doi.org/10.1093/bjsopen/zrac009

Planellas P, Cornejo L, Rodríguez-Hermosa JI, Maldonado E, Timoteo A, Hernández-Yagüe X, Farrés R, Codina-Cazador A

Is Metformin Associated With Improved Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer?

JOURNAL OF SURGICAL RESEARCH, 2021, 268, 465-473 dx.doi.org/10.1016/j.jss.2021.06.079

Planellas P, Farrés R, Cornejo L, Rodríguez-Hermosa JI, Pigem A, Timoteo A, Ortega N, Codina-Cazador A

Randomized clinical trial comparing side to end vs end to end techniques for colorectal anastomosis

INTERNATIONAL JOURNAL OF SURGERY, 2020, 83, 220-229 dx.doi.org/10.1016/j.ijsu.2020.09.039

Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Häring DA, Ramanathan K, Merschhemke M, Kappos L, ASCLEPIOS I and ASCLEPIOS II Trial Groups

Ofatumumab versus Teriflunomide in Multiple Sclerosis

NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383, 546-557 dx.doi.org/10.1056/NEJMoa1917246

Formulari de contacte

About IDIBGI!

menu